GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AItheNutrigene Co Ltd (XKRX:311960) » Definitions » Research & Development

AItheNutrigene Co (XKRX:311960) Research & Development : ₩1,300 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is AItheNutrigene Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. AItheNutrigene Co's Research & Development for the six months ended in Dec. 2024 was ₩1,300 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was ₩1,300 Mil.


AItheNutrigene Co Research & Development Historical Data

The historical data trend for AItheNutrigene Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AItheNutrigene Co Research & Development Chart

AItheNutrigene Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
735.07 1,186.10 1,886.34 2,502.31 1,300.10

AItheNutrigene Co Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development 735.07 1,186.10 1,886.34 2,502.31 1,300.10

AItheNutrigene Co Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was ₩1,300 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AItheNutrigene Co  (XKRX:311960) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


AItheNutrigene Co Research & Development Related Terms

Thank you for viewing the detailed overview of AItheNutrigene Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


AItheNutrigene Co Business Description

Traded in Other Exchanges
N/A
Address
630, 42 Changdeok-ro, Siheung-dong, Pangyo 2nd Techno Valley Gyeonggi Business Growth Center, Sujeong-gu, Gyeonggi-do, Seongnam-si, KOR
AItheNutrigene Co Ltd engages in developing a test-detection solution in order to check out the early detection of various diseases. The company offers molecular diagnostic technology, nutrition therapy customized according to an individual's genomics and AI bio, enabling patients and medical practitioners with tests and accurate diagnoses to prevent diseases.

AItheNutrigene Co Headlines

No Headlines